cystic
fibrosi
cf
inherit
genet
disord
characteris
chronic
pulmonari
diseas
major
caus
morbid
mortal
patient
cf
recent
studi
indic
respiratori
viral
infect
may
preced
pulmonari
exacerb
children
adult
cf
tradit
nasopharyng
aspir
npa
bronchoalveolar
lavag
bal
sampl
specimen
choic
diagnos
respiratori
viru
infect
use
isol
method
direct
fluoresc
antibodi
detect
polymeras
chain
reaction
pcr
pcr
offer
increas
sensit
specif
rapid
turnaround
time
multiplex
format
facilit
detect
rna
dna
sever
virus
singl
reaction
sputum
commonli
use
detect
bacteria
fungi
yeast
patient
cf
detect
respiratori
virus
sputum
technic
difficult
due
viscos
sampl
presenc
multidrugresist
bacteria
rtpcr
use
detect
respiratori
virus
sputum
asthma
patient
recent
develop
multiplexrtpcr
assay
combin
colorimetr
amplicon
detect
mrtpcrelaha
detect
seven
respiratori
virus
npa
noncf
patient
studi
report
assay
use
detect
respiratori
virus
sputa
collect
adult
patient
cf
investig
carri
sputa
cf
patient
hospitalis
respiratori
exacerb
royal
princ
alfr
hospit
rpah
sydney
australia
twentyfour
sputa
collect
patient
juli
septemb
patient
march
august
patient
group
enrol
ten
patient
provid
multipl
sputa
rang
sampl
select
patient
studi
base
product
suffici
sputum
analysi
sputum
sampl
collect
admiss
equal
divid
one
half
sent
routin
microbiolog
test
viru
analysi
patient
repres
patient
popul
rpah
cf
clinic
term
age
sampl
clinic
popul
mean
age
year
year
gender
balanc
ident
baselin
lung
function
predict
sampl
compar
whole
clinic
diagnosi
cf
confirm
case
genotyp
sweat
test
respiratori
exacerb
defin
chang
patient
condit
warrant
intraven
antibiot
therapi
base
deterior
least
four
follow
paramet
sputum
haemoptysi
cough
dyspnoea
malaisefatigu
exercis
toler
fever
anorexia
weight
loss
sinus
forc
vital
capac
forc
expiratori
volum
decreas
previou
record
valu
radiograph
chang
chest
sound
fifteen
patient
experienc
exacerb
preced
month
mean
rang
demograph
characterist
lung
function
number
day
hospit
inpati
concomit
condit
patient
shown
tabl
mrtpcrelaha
use
studi
previous
develop
valid
laboratori
facilit
detect
influenza
flu
influenza
b
flu
b
parainfluenza
virus
respiratori
syncyti
viru
rsv
adenoviru
sputum
sampl
transport
laboratori
ice
store
frozen
await
process
nucleic
acid
extract
ml
sputa
without
pretreat
use
high
viral
nucleic
acid
kit
roch
diagnost
sydney
australia
pool
sputum
cf
patient
shown
neg
virus
seed
known
viru
serv
control
associ
sought
viru
statu
continu
variabl
ie
age
lung
function
inpati
day
use
ttest
viru
statu
dichotom
variabl
ie
gender
concomit
condit
presenc
pathogen
use
chisquar
test
small
number
fisher
exact
test
p
valu
consid
signific
overal
sampl
collect
patient
viru
posit
four
flu
b
three
parainfluenza
three
flu
two
rsv
tabl
three
sampl
posit
compar
flu
flu
b
rsv
detect
sampl
year
parainfluenza
viru
detect
parainfluenza
virus
adenoviru
detect
sampl
either
year
six
seven
patient
test
posit
flu
flu
b
known
vaccin
statu
four
vaccin
year
virusposit
sputum
sampl
obtain
signific
differ
male
femal
ratio
age
lung
function
number
hospit
inpati
day
number
exacerb
last
month
virusposit
neg
group
tabl
seven
patient
viru
isol
nonvirusrel
exacerb
statist
associ
viru
statu
demograph
clinic
variabl
isol
rate
pseudomona
aeruginosa
p
aeruginosa
staphylococcu
aureu
aureu
aspergillu
fumigatu
fumigatu
virusposit
patient
bacteri
pathogen
isol
sputum
collect
month
prior
lung
exacerb
one
patient
small
coliform
present
exacerb
sputum
isol
previous
role
virus
clinic
cours
cf
infect
clearli
defin
howev
virus
identifi
npa
bal
sampl
infant
young
children
link
pulmonari
exacerb
earli
acquisit
p
aeruginosa
advers
clinic
cours
rsv
seem
commonli
involv
two
recent
serolog
studi
older
children
adult
flu
flu
b
associ
sever
pulmonari
deterior
also
report
identif
rhinoviru
picornavirus
npa
patient
pulmonari
exacerb
result
pilot
studi
show
mrtpcrelaha
success
use
detect
sever
common
respiratori
virus
cf
sputum
report
previous
preval
viral
respiratori
infect
cf
patient
vari
markedli
accord
specimen
type
detect
method
target
virus
patient
age
preval
found
studi
consist
find
deriv
adult
seri
use
serolog
assay
similar
spectrum
virus
modif
protocol
incorpor
parvoviru
rhinoviru
human
coronaviru
human
metapneumoviru
would
almost
certainli
increas
rate
posit
result
temper
region
australia
infect
parainfluenza
virus
adenovirus
occur
throughout
year
low
incid
level
infect
rsv
occur
primarili
autumn
earli
winter
whilst
influenza
outbreak
usual
occur
winter
month
sampl
studi
collect
winter
month
higher
rate
flu
flu
b
detect
compar
consist
data
gener
popul
show
moder
increas
influenza
activ
typic
flu
b
peak
earli
winter
flu
later
season
flu
flu
b
ratio
respect
small
sampl
cf
patient
virus
detect
similar
proport
year
trend
could
explain
collect
pattern
influenza
vaccin
often
recommend
patient
cf
four
seven
patient
test
posit
flu
flu
b
present
studi
vaccin
current
year
known
seroconvert
recent
cochran
review
found
randomis
trial
examin
benefit
influenza
vaccin
patient
cf
studi
need
definit
conclus
may
reach
find
studi
suggest
sputum
may
viabl
noninvas
altern
bal
npa
sampl
detect
respiratori
virus
cf
patient
howev
studi
compar
rate
viru
detect
cf
sputum
use
rtpcrelaha
achiev
use
convent
method
viru
isol
serolog
npa
bal
need
confirm
sensit
assay
applic
clarif
role
respiratori
virus
clinic
cours
cf
infect
assum
increas
import
advent
new
antivir
agent
pulmonari
infect
avail
rapid
sensit
diagnost
test
detect
multipl
common
virus
would
greatli
facilit
investig
assum
import
viral
infect
establish
incorpor
assay
clinic
manag
program
potenti
reduc
morbid
enhanc
surviv
cf
patient
